Ed Esplin

Ed Esplin: Is There Any Patient Who Should Not Have Germline Genetic Testing to Aid Treatment Decision Making?

Ed Esplin, Clinical Geneticist at Invitae, shared on X:

“2026 NCCN Genetic guidelines page CRIT-1

“GENERAL TESTING CRITERIA

Germline testing is clinically indicated in the following scenarios: To aid in systemic therapy and surgical decision-making”

Is there any patient with breast, ovarian, pancreas, prostate, colorectal, gastric, endometrial cancer who should not have germline genetic testing to aid in systemic therapy and surgical decision making?”

Title: Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis

Authors: Vivek Subbiah, Razelle Kurzrock

Read The Full Article at JCO ASCO.

Ed Esplin: Is There Any Patient Who Should Not Have Germline Genetic Testing to Aid Treatment Decision Making?

More posts featuring Germline Genetic Testing.

cancer Ed Esplin germline genetic testing NCCN Genetic guidelines OncoDaily Oncology Razelle Kurzrock Vivek Subbiah